Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Hadzovic S"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hadzovic S; Faculty of Electrical Engineering, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina., Mrdovic S; Faculty of Electrical Engineering, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina., Radonjic M; Faculty of Electrical Engineering, University of Montenegro, 81000 Podgorica, Montenegro.
Publikováno v:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2021 Mar 17; Vol. 21 (6). Date of Electronic Publication: 2021 Mar 17.
Autor:
Mccafferty K; Department of Nephrology, Barts Health NHS Trust, London, UK., Caplin B; Centre for Nephrology, University College London Medical School, London, UK., Knight S; Department of Discovery Biology, Discovery Sciences, R&D, AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK., Hockings P; Antaros Medical, Gothenburg, Sweden.; MedTech West, Chalmers University of Technology, Goteborg, Sweden., Wheeler D; Centre for Nephrology, University College London Medical School, London, UK., Fan SL; Department of Nephrology, Barts Health NHS Trust, London, UK., Hulthe J; Antaros Medical, Gothenburg, Sweden., Kleta R; Divison of Medicine, University College London, London, UK., Ashman N; Department of Nephrology, Barts Health NHS Trust, London, UK., Papastefanou V; Barts Health NHS Trust, London, UK., Mehta H; Royal Free Hampstead NHS Trust, London, London, UK., Salama A; Divison of Medicine, University College London, London, UK., Hadzovic S; Department of BioPharma Early Biometrics and Statistical Innovation, AstraZeneca, Goteborg, Sweden., Chowdhury TA; Department of Diabetes and Metabolism, Barts Health NHS Trust, London, UK., Jarl L; Antaros Medical, Gothenburg, Sweden., Unwin R; Department of Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK., Challis B; Department of Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK., Sundgren AK; Department of Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.; Data Science & AI | BioPharma Early Biometrics and Statistical Innovation, AstraZeneca, Gothenburg, Sweden., Yaqoob MM; Department of Nephrology, Barts Health NHS Trust, London, UK m.m.yaqoob@qmul.ac.uk.
Publikováno v:
BMJ open [BMJ Open] 2020 Sep 09; Vol. 10 (9), pp. e033923. Date of Electronic Publication: 2020 Sep 09.
Autor:
Zhou Y; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Bruijnzeel PL; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., McCrae C; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Zheng J; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Nihlen U; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Zhou R; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Van Geest M; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Nilsson A; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Hadzovic S; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Huhn M; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Taib Z; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Gu Y; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Xie J; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Ran P; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Chen R; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden., Zhong N; 1 The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510182, China ; 2 Early Clinical Development, 3 Translational Science, Respiratory, Inflammation and Autoimmunity iMed, AstraZeneca, Mölndal, Sweden ; 4 Translational Science, Asia & Emerging Markets iMed, AstraZeneca, Shanghai 201203, China ; 5 GMED RIA, 6 Statistical Department, 7 Programming Department, AstraZeneca, Mölndal, Sweden.
Publikováno v:
Journal of thoracic disease [J Thorac Dis] 2015 Apr; Vol. 7 (4), pp. 720-33.
Publikováno v:
Pharmacology. 10:303-306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6644c2e0ae342940bf362085fbe4cba
https://doi.org/10.1159/000135431
https://doi.org/10.1159/000135431
Autor:
Zaidan, Esmat, Ibrahim, Imad Antoine
Publikováno v:
Humanities & Social Sciences Communications; 9/1/2024, p1-18, 18p
Autor:
Vehabovic M; Bosnalijek d.d., Jukiceva 55, 71000, Sarajevo, Bosnia and Herzegovina., Hadzovic S, Stambolic F, Hadzic A, Vranjes E, Haracic E
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2003 Apr 30; Vol. 256 (1-2), pp. 109-15.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yang, Yingjian1,2 (AUTHOR), Wang, Shicong2,3 (AUTHOR), Zeng, Nanrong2,3 (AUTHOR), Duan, Wenxin2,3 (AUTHOR), Chen, Ziran2 (AUTHOR), Liu, Yang2 (AUTHOR), Li, Wei2 (AUTHOR), Guo, Yingwei1,2 (AUTHOR), Chen, Huai4 (AUTHOR), Li, Xian4 (AUTHOR), Chen, Rongchang5,6,7 (AUTHOR) chenrc@vip.163.com, Kang, Yan1,2,3,8 (AUTHOR) chenrc@vip.163.com
Publikováno v:
Diagnostics (2075-4418). Oct2022, Vol. 12 Issue 10, p2274-N.PAG. 21p.